Avricore Health (AVCRF) FCF Margin (2009 - 2025)

Avricore Health has disclosed FCF Margin across 13 years of filings, most recently posting 1085.75% for Q3 2025.

• In Q3 2025, FCF Margin fell 115550.0% year-over-year to 1085.75%; the TTM figure through Sep 2025 stood at 15.01% (down 6654.0% YoY), while the FY2025 annual figure was 131.38%, down 15616.0% from the prior year.
• FCF Margin fell to 1085.75% in Q3 2025, from 417.03% in the prior quarter.
• Over the last five years, FCF Margin for AVCRF reached as high as 109.67% in Q3 2022 and fell as low as 6204.37% in Q2 2021.
• The 5-year median for FCF Margin is 46.19% (2024), against an average of 748.38%.
• Annual changes were most pronounced in 2021 — FCF Margin tumbled 372132 bps — and 2022, when it jumped 606906 bps.
• A 5-year view of FCF Margin shows it stood at 1359.57% in 2021, then jumped by 85 bps to 202.79% in 2022, then surged by 122 bps to 43.66% in 2023, then surged by 60 bps to 69.75% in 2024, then plunged by 1657 bps to 1085.75% in 2025.
• According to Business Quant data, FCF Margin over the past three periods registered 1085.75%, 417.03%, and 65.95% for Q3 2025, Q2 2025, and Q1 2025 respectively.